文献速递主动脉疾病外周动脉疾病

髂分支装置应用经验:单中心157例连续手术10年结果

Lesson Learned with the Use of Iliac Branch Devices: Single Centre 10 Year Experience in 157 Consecutive Procedures.
PubMed 文献 · Eur J Vasc Endovasc Surg · 2017-05-07

单中心前瞻性数据库纳入2006至2016年157例连续髂分支装置(IBD)手术,技术成功率97.5%,平均随访44.2个月,9年免于IBD相关再干预率91.8%,髂内动脉10年通畅率90.4%。同侧髂内动脉瘤及研究早期手术为早期失败预测因素,髂内动脉瘤为随访期靶血管闭塞独立预测因素。

要点

  • IBD技术成功率达97.5%,长期免于再干预率与标准主动脉腔内修复相当。
  • 同侧髂内动脉瘤和研究早期手术是早期失败的预测因素。
  • 髂内动脉瘤是随访期靶血管闭塞的独立预测因素。

核心结论

  • 髂分支装置手术技术成功率高,长期免于再干预率与标准主动脉腔内修复患者相当。
  • 对于血管解剖合适但不适合标准腔内主动脉修复的患者,IBD应视为首选治疗。

研究设计与样本

  • 单中心前瞻性数据库研究,2006至2016年连续157例IBD手术,149例患者接受髂分支内移植物治疗。
  • 适应证包括单侧或双侧髂总动脉瘤,合并或不合并腹主动脉瘤;采用Kaplan-Meier法报告远期结果。

主要发现

  • 技术成功率为97.5%,孤立性IBD植入占17.8%。
  • 围手术期手术失败7例,其中4例术中、3例术后30天内。
  • 多因素分析显示,同侧髂内动脉瘤(p = .031;Exp [B] = 6.72)和研究初期手术(p = .006;Exp [B] = 10.40)可预测早期失败。
  • 平均随访44.2个月,免于IBD相关再干预率在1、3、5、9年分别为97.4%、95.6%、94.0%、91.8%。
  • 髂内动脉通畅率在1、3、10年分别为94.7%、92.6%、90.4%;髂内动脉瘤为随访期靶血管闭塞的独立预测因素(p = .007;Exp [B] = 5.93)。

临床怎么用

  • IBD可用于解剖适合但不适合标准EVAR的广泛主髂动脉瘤患者,作为首选治疗。
  • 合并同侧髂内动脉瘤者应警惕早期失败风险,研究初期开展IBD也与早期失败相关。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE/BACKGROUND: Absence of an adequate iliac seal rarely represents an absolute contraindication to endovascular abdominal aortic aneurysm repair. Iliac branch devices (IBD) are increasingly used in patients with extensive aorto-iliac aneurysmal disease, but few data are available on the long-term results of these procedures. METHODS: Between 2006 and 2016, 157 consecutive IBD procedures performed at a single centre were entered into a prospective database. Indications included unilateral or bilateral common iliac artery aneurysms combined or not with abdominal aortic aneurysms. Long-term results were reported according to the Kaplan-Meier method. RESULTS: During the study period 149 patients were treated with an iliac branched endograft. Isolated IBD was implanted in 17.8% of the cases; technical success rate was 97.5%. Peri-operative procedure failure occurred in seven patients, four during surgery and three within 30 days of the procedure. Presence of ipsilateral hypogastric aneurysm (p = .031; Exp [B] = 6.72) and intervention performed during the initial study period (p = .006; Exp [B] = 10.40) were predictive of early failure on multivariate analysis. After a mean follow-up of 44.2 months actuarial freedom from IBD related re-intervention was 97.4%, 95.6%, 94.0%, and 91.8% at 1, 3, 5, and 9 years, respectively. Hypogastric artery patency was 94.7%, 92.6%, and 90.4% at 1, 3, and 10 years, respectively. Presence of a hypogastric aneurysm was an independent predictor of target artery occlusion during follow-up on multivariate analysis (p = .007; Exp [B] = 5.93). CONCLUSION: Iliac branched endografting can now be performed with a high technical success rate; long-term freedom from re-intervention is comparable with patients treated with standard aortic endografting. IBD should be considered a first-option treatment in patients with adequate vascular anatomy unsuitable for standard endovascular aortic repair.

来源:Eur J Vasc Endovasc Surg,查看原文。版权归原作者所有。

引用

  1. Simonte G, Parlani G, Farchioni L, et al. Lesson Learned with the Use of Iliac Branch Devices: Single Centre 10 Year Experience in 157 Consecutive Procedures. Eur J Vasc Endovasc Surg. 2017. PMID: 28495214. doi:10.1016/j.ejvs.2017.03.026

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。